14 results
8-K
EX-10.1
SMTI
Sanara MedTech Inc
8 Jul 13
Entry into a Material Definitive Agreement
12:00am
(3) days after becoming aware of any patient safety issue involving any Product. If any Product or any of its components is subject to recall … as that term is defined under 21 C.F.R. Part 7, or a voluntary recall by Manufacturer, or is subject to an FDA-initiated court action for removing
8-K
EX-10.1
106ajcrbqamcbofpg6e
19 Jul 21
Sanara MedTech Inc. Announces the Purchase of Certain Assets from Rochal Industries, LLC
4:47pm
424B5
ur92t
16 Feb 21
Prospectus supplement for primary offering
4:52pm
424B5
g1qoq9r
11 Feb 21
Prospectus supplement for primary offering
4:06pm
8-K
EX-1.1
fv2pbwt8 az
17 Feb 21
Sanara MedTech Inc. Announces Proposed Public Offering of Common Stock
4:29pm
8-K
EX-2.1
866cj
5 Jul 22
Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition
9:20am
8-K
EX-2.1
jl6b5hrer ll5fjehfq
4 Apr 22
Entry into a Material Definitive Agreement
6:34am
- Prev
- 1
- Next